Author:
Galmarini Carlos M.,Myhren Finn,Sandvold Marit L.
Reference10 articles.
1. 725 POSTER A multicenter phase I study of a novel nucleoside analogue, CP-4126, in patients with advanced solid tumours – preliminary results
2. Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells;Adams;Leukaemia & Lymphoma,2008
3. Fatty acid derivatives of cytarabine and gemcitabine, CP-4055 and CP-4126, show a prolonged cellular retention compared to the parent drug;Adema;Proceedings of the American Association for Cancer Research,2008
4. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines;Bergman;Nucleosides Nucleotides Nucleic Acids,2004
5. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models;Breistol;Cancer Research,1999
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献